Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK

Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England

(2015) T. L. Chin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China

(2015) Ya Li et al.   PLoS One

Prokka: rapid prokaryotic genome annotation

(2014) T. Seemann   BIOINFORMATICS

Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream Infections

(2014) M. Doumith et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Comprehensive Antibiotic Resistance Database

(2013) Andrew G. McArthur et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genomewide Overexpression Screen for Fosfomycin Resistance in Escherichia coli: MurA Confers Clinical Resistance at Low Fitness Cost

(2012) Alejandro Couce et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae

(2012) Fernando Pasteran et al.   Journal of Infection in Developing Countries

Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods

(2011) Ching-Lan Lu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The revival of fosfomycin

(2011) Argyris S. Michalopoulos et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin

(2010) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli

(2010) Sho Takahata et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fosfomycin susceptibility among extended-spectrum- -lactamase-producing Escherichia coli in Nottingham, UK

(2010) R. J. Chislett et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Susceptibility of Urinary Tract Bacteria to Fosfomycin

(2009) S. Maraki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fosfomycin: an old, new friend?

(2009) M. Popovic et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Has the era of untreatable infections arrived?

(2009) D. M. Livermore   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review

(2009) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES

Potential of old-generation antibiotics to address current need for new antibiotics

(2008) Matthew E Falagas et al.   Expert Review of Anti-Infective Therapy